# Prospective Evaluation of Oral Antibiotics for Treatment of Shoulder PJI

> **NCT04636125** · PHASE3 · UNKNOWN · sponsor: **Rothman Institute Orthopaedics** · enrollment: 100 (actual)

## Conditions studied

- Periprosthetic Infection
- Oral Antibiotics
- Revision Total Shoulder Arthroplasty

## Interventions

- **DRUG:** Doxycycline 100 MG Oral Tablet

## Key facts

- **NCT ID:** NCT04636125
- **Lead sponsor:** Rothman Institute Orthopaedics
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-24
- **Primary completion:** 2021-09-24
- **Final completion:** 2021-09-24
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04636125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04636125, "Prospective Evaluation of Oral Antibiotics for Treatment of Shoulder PJI". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04636125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
